# Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome

> **NCT01883076** · PHASE1 · COMPLETED · sponsor: **Timothy J Nelson, MD, PhD** · enrollment: 30 (estimated)

## Conditions studied

- Hypoplastic Left Heart Syndrome

## Interventions

- **BIOLOGICAL:** autologous cell-based delivery

## Key facts

- **NCT ID:** NCT01883076
- **Lead sponsor:** Timothy J Nelson, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-15
- **Primary completion:** 2021-04-28
- **Final completion:** 2021-04-28
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-04-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01883076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01883076, "Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01883076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*